Wound Healing Startup SironRX Hires New CEO, Gets OK on Clinical Trial

Regenerative medicine wound healing company SironRX Therapeutics has hired a first-time CEO as its first-ever, full-time CEO. Evan Facher most recently worked as general manager of Pittsburgh interventional operations with MedRad, a medical device company that’s an arm of Bayer HealthCare. In eight years with MedRad, Facher held a variety of roles that included business development, product development and overseeing M&A activities. Prior to that, he was in business development with Cleveland-based stem cell developer Athersys.

MORE ON THIS TOPIC